GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC18397 structure
    GC18397R-(-)-α-Methylhistamine (hydrochloride)
    CAS: 75614-89-0
    Purity: >98.00%

    R-(-)-α-Méthylhistamine (chlorhydrate) est un agoniste puissant, sélectif et pénétrant dans le cerveau du récepteur de l'histamine H3, avec un Kd de 50,3 nM.

  • GC18426 structure
    GC184268-Nitroguanine
    CAS: 168701-80-2
    Purity: >98%

    8-Nitroguanine is a nitrative guanine derivative formed by oxidative damage to the guanine base in DNA by reactive nitrogen species (RNS) during inflammation and in vitro by reaction of DNA with peroxynitrite and other RNS reagents.

  • GC18443 structure
    GC18443Acetyl-6-formylpterin
    CAS: 29769-49-1
    Purity: >98%

    Acetyl-6-formylpterin is an inhibitor of mucosal-associated invariant T (MAIT) cell activation.

  • GC18449 structure
    GC18449Cardanol monoene
    CAS: 501-26-8
    Purity: >98%

    Le cardanol monoène (Cardanol C15:1) est un composé phénolique présent dans le liquide de coque de noix de cajou. Le monoène de cardanol peut induire l'apoptose associée aux mitochondries dans les cellules de mélanome humain.

  • GC18453 structure
    GC18453Sulochrin
    CAS: 519-57-3
    Purity: >98.00%

    Sulochrine est un métabolite fongique produit par A.

  • GC18469 structure
    GC18469Galactosylcerebrosides (bovine)
    CAS: 85305-88-0
    Purity: >98.00%

    Galactosylcerebrosides are glycosphingolipids that contain a galactose attached to a ceramide acylated with hydroxy and non-hydroxy fatty acids.

  • GC18478 structure
    GC18478MPLA
    CAS: 1246298-63-4
  • GC18487 structure
    GC18487BC-1215
    CAS: 1507370-20-8
    Purity: >99.50%

    BC-1215 est un inhibiteur de la protéine F-box 3 (Fbxo3).

  • GC18488 structure
    GC18488Cyclo(L-Leu-L-Trp)
    CAS: 15136-34-2
    Purity: >98%

    Cyclo(L-Leu-L-Trp) is a diketopiperazine metabolite originally isolated from Penicillium.

  • GC18489 structure
    GC18489Neamine (hydrochloride)
    CAS: 15446-43-2
    Purity: >98%

    La néamine (chlorhydrate), un produit de dégradation de la néomycine, est un antibiotique aminoglycoside À large spectre.

  • GC18498 structure
    GC18498Cathepsin L Inhibitor (Z-FY-CHO)
    CAS: 167498-29-5
    Purity: >98.00%

    Cathepsin L Inhibitor (Z-FY-CHO) est un composé capable d'inhiber spécifiquement l'activité de Cathepsin L (Ki = 0.185nM), utilisé pour étudier le rôle de cette enzyme dans la fonction lysosomale et la dégradation protéique cellulaire.

  • GC18499 structure
    GC18499Erythromycin C
    CAS: 1675-02-1
    Purity: >98%

    Erythromycin C is an intermediate in the biosynthesis of erythromycin .

  • GC18510 structure
    GC18510Siccanin
    CAS: 22733-60-4
    Purity: >98%

    Siccanin is an inhibitor of mitochondrial complex II (succinate dehydrogenase; IC50s = 0.87 and 9.3 μM for P.

  • GC18517 structure
    GC18517Diapocynin
    CAS: 29799-22-2
    Purity: >98%

    Diapocynin is the dimeric form of the NADPH oxidase inhibitor apocynin that has anti-inflammatory and antioxidant activities.

  • GC18522 structure
    GC18522Phosphatidylserines (sodium salt)
    CAS: 383908-63-2
    Purity: >95.00%

    Phosphatidylserine is a naturally occurring phospholipid that comprises 2-10% of total phospholipids in mammals and is enriched in the central nervous system, particularly the retina.

  • GC18527 structure
    GC185274'-hydroxy Flurbiprofen
    CAS: 52807-12-2
    Purity: >98%

    A major active metabolite of flurbiprofen

  • GC18536 structure
    GC18536Chartreusin
    CAS: 6377-18-0
    Purity: >98%

    Chartreusin is an antibiotic originally isolated from S.

  • GC18552 structure
    GC18552Lipoxin A4
    CAS: 89663-86-5
    Purity: >95.00%

    Un acide gras trihydroxylé contenant un tétraène conjugué.

  • GC18572 structure
    GC18572Concanavalin A
    CAS: 11028-71-0

    Concanavalin A appartient aux concanamycines, une famille d'antibiotiques macrolides isolés à partir de Streptomyces diastatochromogenes qui sont les inhibiteurs très actifs et sélectifs de la proton-ATPase vacuolaire (v-[H[+]]ATPase).

  • GC18580 structure
    GC18580B355252
    CAS: 1261576-81-1
    Purity: >98%

    Le B355252, une petite molécule de phénoxy thiophène sulfonamide, est un puissant agoniste des récepteurs du NGF.

  • GC18582 structure
    GC185825'-hydroxy Meloxicam
    CAS: 130262-92-9
    Purity: >98%

    A metabolite of meloxicam

  • GC18583 structure
    GC18583D-α-Hydroxyglutaric Acid
    CAS: 13095-47-1
    Purity: >98.00%

    D-α-Hydroxyglutaric Acid est un antagoniste compétitif faible de α‑cétoglutarate (α‑KG) (K i = 10.87mM).

  • GC18601 structure
    GC18601Stachybotrylactam
    CAS: 163391-76-2
    Purity: >98%

    Stachybotrylactam is a spirodihydrobenzofuranlactam mycotoxin originally isolated from Stachybotrys with antiviral activity.

  • GC18602 structure
    GC18602p38 MAPK Inhibitor IV
    CAS: 1638-41-1
    Purity: >98.00%

    p38 MAPK Inhibitor IV est un p38α compétitif pour l'ATP hautement spécifique; Inhibiteur de MAPK avec IC50 de 0,13 et 0,55 μ ; M pour p38α ; et p38β ; MAPK, respectivement.